Full text
1/2018
Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation of one-year outcomes of omalizumab treatment in severe allergic asthma
Data publikacji online: 2018/09/12
Article file
This is an Open Access journal, all articles are distributed under the
terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC
BY-NC-SA
4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to
copy
and redistribute the material in any medium or format and to remix, transform, and build upon
the
material, provided the original work is properly cited and states its license.